Sat, Jul 12, 2014, 1:18 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

MannKind Corp. Message Board

eldercareattorney 1 post  |  Last Activity: May 19, 2014 3:54 PM Member since: Aug 25, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • eldercareattorney by eldercareattorney May 19, 2014 3:54 PM Flag

    On the last call, management said, they didn't know if they'd spend the money on a booth at the ADA but would be at the ADA presenting even if they didn't have a booth. Essentially, they said, if they didn't have approval, there would be nothing to talk about from the booth and the cost of the booth would be warranted if they didn't have approval.

    Now, I don't know, but my guess is, a booth doesn't cost more than $10K. They've spent about $1.5B so far on Afrezza and will be presenting clinical data from the Affinity Trials at the ADA. So, does anyone seriously believe that the cost of the booth is really the deciding factor as to whether or not they will have a booth.

    Recently, someone said that Merck American Diabetes Challenged did a late booking of the booth next to the booth assigned the MNKD. If this is true, I'd bet dollars to doughnuts that MRK is the partner.

MNKD
10.07+0.18(+1.82%)Jul 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Potbelly Corporation
NasdaqGSFri, Jul 11, 2014 4:00 PM EDT
ACI Worldwide, Inc.
NasdaqGSFri, Jul 11, 2014 4:00 PM EDT